Nigeria to Receive 7.7 Million Doses of China’s Sinopharm COVID Vaccine
-
Nigeria has approved China’s Sinopharm COVID Vaccine for use in the country, according to the National Primary Health Care Development Agency (NPHCDA)
-
The country is now set to receive 7.7 million doses of the vaccine through the COVAX scheme
-
The head of NPHCDA, Dr Faisal Shuaib did not say when the vaccines will arrive but the country has already begun phase 2 vaccination this month
The National Primary Health Care Development Agency (NPHCDA) has approved China’s Sinopharm COVID Vaccine for use in Nigeria.
The country has been allocated 7.7 million doses of the vaccine through the COVAX scheme, an organization that aims at providing vaccines to developing countries.
NPHCDA boss Dr Faisal Shuaib however did not give any information about when the vaccines will be received.
Nigeria has received almost 5 million doses of vaccine in August as the country intensifies its effort against the third wave of the pandemic.
Africa’s most populous country has only vaccinated a small portion of its population due to the low supply of the vaccine.
The country began phase 2 vaccination on Aug. 16 after receiving supplies of Moderna and Jansen vaccines.
Since the start of the pandemic, Nigeria has recorded 187,588 cases of COVID-19 while 2,276 have died from the virus.
Follow Naija.fm on our social media handles Facebook, Instagram, and Twitter to keep up with trending news, breaking news, entertainment news.
